# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-19-000451
Filing Date
2019-08-08
Accepted
2019-08-08 16:36:38
Documents
71
Period of Report
2019-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | riot_10q-063019.htm | 10-Q | 478676
2 | EXHIBIT 31.1 | ex31x1.htm | EX-31.1 | 7415
3 | EXHIBIT 31.2 | ex31x2.htm | EX-31.2 | 7562
4 | EXHIBIT 32 | ex32.htm | EX-32 | 4157
| Complete submission text file | 0001079973-19-000451.txt |  | 4064815

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL INSTANCE FILE | riot-20190630.xml | EX-101.INS | 567373
6 | XBRL SCHEMA FILE | riot-20190630.xsd | EX-101.SCH | 62284
7 | XBRL CALCULATION FILE | riot-20190630_cal.xml | EX-101.CAL | 80605
8 | XBRL DEFINITION FILE | riot-20190630_def.xml | EX-101.DEF | 294692
9 | XBRL LABEL FILE | riot-20190630_lab.xml | EX-101.LAB | 478511
10 | XBRL PRESENTATION FILE | riot-20190630_pre.xml | EX-101.PRE | 371416

Mailing Address 202 6TH STREET, SUITE 401 CASTLE ROCK CO 80104
Business Address 202 6TH STREET, SUITE 401 CASTLE ROCK CO 80104 303-794-2000
Riot Blockchain, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33675 | Film No.: 191010102
SIC: 2835 In Vitro & In Vivo Diagnostic Substances